Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Клинический опыт амбулаторного ведения пациентов с болью в спине
Клинический опыт амбулаторного ведения пациентов с болью в спине
В.А.Парфенов, О.Н.Герасимова. Клинический опыт амбулаторного ведения пациентов с болью в спине. Consilium Medicum. Неврология (Прил.). 2013; 1: 5-7.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Подчуфарова Е.В., Яхно Н.Н. Боли в спине и конечностях. В кн.: Болезни нервной системы. Руководство для врачей. Под редакцией Н.Н.Яхно, М., 2005. Т. 2.; с. 306–31.
2. Подчуфарова Е.В., Яхно Н.Н. Боль в спине. М., 2010.
3. Bogduk N, McGuirk B. Medical management of acute and chronic low back pain. Amsterdam: Elsevier, 2002.
4. Dulin J, Kovacs L, Ramm S et al. Evaluation of sedative effects of single and repeated doses of 50 mg and 150 mg tolperisone hydrochloride. Results of a prospective, randomized, double-blind, placebo-controlled trial. Pharmacopsychiat 1998; 31: 137–42.
5. Van Tulder M, Becker A, Bekkering T et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J 2006; 15 (Suppl. 2): S169–S191.
6. Chou R, Atlas SJ, Stanos SP, Rosenquist RW. Nonsurgical interventional therapies for low back pain: a review of the evidence for an American Pain Society clinical practice guideline. Spine 2009; 34: 1078–93.
7. Гурак С.В., Парфенов В.А., Борисов К.Н. Мидокалм в комплексной терапии острой поясничной боли. Боль. 2006; 3: 27–30.
8. Pratzel HG, Alken R-G, Ramm S. Efficacy and tolerance of repeated doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial. Pain 1996; 67: 417–25.
9. Парфенов В.А., Герасимова О.Н. Использование ацеклофенака (аэртал) при неспецифической боли в спине и других заболеваниях. Неврология, нейропсихиатрия, психосоматика. 2011; 4: 99–102.
10. Huskisson E, Irani M, Murray F. A large prospective open-label, multicentre SAMM study, comparing the safety of aceclofenac with diclofenac in patients with rheumatic disease. Eur J Rheumatol Inflamm 2000; 17: 1–7.
11. Lemmel EM et al. Patient and Physician Satisfaction with aceclofenac results of the European Observational Cohort study (experiens with aceclofenac for inflammatory pain in daily practice). Curr Med Res Opin 2002; 18 (3): 146–53.
12. Pareek A, Chandurkar N, Chandanwale AS et al. Aceclofenac-tizanidine in the treatment of acute low back pain: a double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone. Eur Spine J 2009; 18: 1836–42.
13. Schattenkirchner M, Milachowsk KA. A double-blind, multi-center clinical trial compuring the efficacy and tolerability of aceclofenac with diclofenac – resinate in patients with acute low back pain. Clin Rheumatol 2003; 22: 127–35.
14. Hayden JA, van Tulder MW, Malmivaara A, Koes BW. Exercise therapy for treatment of non-specific low back pain. Cochrane Database Syst Rev 2005; 3: CD000335.
15. Dworkin RH, O'Connor AB, Backonja M et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007; 132: 237–51.
16. Melero LMJ, Burillo TJM, Zaragoza M. Comparative incidence of upper gastrointestinal bleeding associated with individual non-steroidal anti-inflammatory drugs. Rev Esp Enferm Dig 2002; 94: 7–18.
17. Lapeyre-Mestre M, Grolleau S, Montastruc JL. Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002–2006. Fundam Clin Pharmacol 2011.
2. Подчуфарова Е.В., Яхно Н.Н. Боль в спине. М., 2010.
3. Bogduk N, McGuirk B. Medical management of acute and chronic low back pain. Amsterdam: Elsevier, 2002.
4. Dulin J, Kovacs L, Ramm S et al. Evaluation of sedative effects of single and repeated doses of 50 mg and 150 mg tolperisone hydrochloride. Results of a prospective, randomized, double-blind, placebo-controlled trial. Pharmacopsychiat 1998; 31: 137–42.
5. Van Tulder M, Becker A, Bekkering T et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J 2006; 15 (Suppl. 2): S169–S191.
6. Chou R, Atlas SJ, Stanos SP, Rosenquist RW. Nonsurgical interventional therapies for low back pain: a review of the evidence for an American Pain Society clinical practice guideline. Spine 2009; 34: 1078–93.
7. Гурак С.В., Парфенов В.А., Борисов К.Н. Мидокалм в комплексной терапии острой поясничной боли. Боль. 2006; 3: 27–30.
8. Pratzel HG, Alken R-G, Ramm S. Efficacy and tolerance of repeated doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial. Pain 1996; 67: 417–25.
9. Парфенов В.А., Герасимова О.Н. Использование ацеклофенака (аэртал) при неспецифической боли в спине и других заболеваниях. Неврология, нейропсихиатрия, психосоматика. 2011; 4: 99–102.
10. Huskisson E, Irani M, Murray F. A large prospective open-label, multicentre SAMM study, comparing the safety of aceclofenac with diclofenac in patients with rheumatic disease. Eur J Rheumatol Inflamm 2000; 17: 1–7.
11. Lemmel EM et al. Patient and Physician Satisfaction with aceclofenac results of the European Observational Cohort study (experiens with aceclofenac for inflammatory pain in daily practice). Curr Med Res Opin 2002; 18 (3): 146–53.
12. Pareek A, Chandurkar N, Chandanwale AS et al. Aceclofenac-tizanidine in the treatment of acute low back pain: a double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone. Eur Spine J 2009; 18: 1836–42.
13. Schattenkirchner M, Milachowsk KA. A double-blind, multi-center clinical trial compuring the efficacy and tolerability of aceclofenac with diclofenac – resinate in patients with acute low back pain. Clin Rheumatol 2003; 22: 127–35.
14. Hayden JA, van Tulder MW, Malmivaara A, Koes BW. Exercise therapy for treatment of non-specific low back pain. Cochrane Database Syst Rev 2005; 3: CD000335.
15. Dworkin RH, O'Connor AB, Backonja M et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007; 132: 237–51.
16. Melero LMJ, Burillo TJM, Zaragoza M. Comparative incidence of upper gastrointestinal bleeding associated with individual non-steroidal anti-inflammatory drugs. Rev Esp Enferm Dig 2002; 94: 7–18.
17. Lapeyre-Mestre M, Grolleau S, Montastruc JL. Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002–2006. Fundam Clin Pharmacol 2011.
Авторы
В.А.Парфенов1, О.Н.Герасимова2
1 ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава РФ;
2 Поликлиника №7 ЗАО «Медицинские услуги», Москва
1 ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава РФ;
2 Поликлиника №7 ЗАО «Медицинские услуги», Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.